Related Experiment Video
Updated: May 23, 2026

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System
Published on: May 1, 2019
Bioanalytical method development, pharmacokinetics, and toxicity studies of paromomycin and paromomycin loaded in
Wahid Khan1, Shyam S Sharma, Neeraj Kumar
1Department of Pharmaceutics, National Institute of Pharmaceutical Education & Research (NIPER), S.A.S., Nagar, India.
Abstract:
Intracellular location of leishmania parasite in macrophages protects them from both hosts defence system as well as from antibiotics like paromomycin (PM) acting against them, thus there is a need of a formulation targeting intracellular parasites. Considering this, PM-loaded albumin microspheres (PM-MS) were prepared to target PM to macrophages where leishmania parasites resides and evaluated for their safety profile. A new bioanalytical method for quantitative determination of PM in rat plasma was developed by pre-column derivatization with 9-fluorenylmethyl chloroformate. The developed bioanalytical method was validated and applied for pharmacokinetic studies of PM administered by intramuscular and intravenous routes as well as for developed PM-MS which were administered by intravenous route. Comparative acute and subacute toxicity studies were also carried out for these formulations. The developed method was found to be very sensitive with a quantification limit of 40 ng/ml. Pharmacokinetic studies demonstrated nearly 80% reduction in C(max) of PM when administered as PM-MS, compared to other formulations at equivalent dose. Toxicity studies indicated increased level of blood urea and blood urea nitrogen in PM intramuscular injection at 90 mg/kg dose, whereas at the same dose level PM-MS showed no symptoms of toxicity. Results obtained suggest that developed PM-MS formulation is a promising alternative to the presently marketed PM intramuscular injection for the treatment of visceral leishmaniasis.
Insights
New albumin microspheres effectively deliver paromomycin (PM) to target intracellular leishmania parasites. This formulation shows improved safety and efficacy compared to traditional PM injections for visceral leishmaniasis treatment.
Area of Science:
- Pharmacology
- Drug Delivery
- Parasitology
Background:
- Leishmania parasites reside intracellularly within macrophages, evading host defenses and antibiotics like paromomycin (PM).
- Targeting intracellular parasites requires specialized drug delivery systems to enhance therapeutic efficacy.
Purpose of the Study:
- To develop and evaluate paromomycin-loaded albumin microspheres (PM-MS) for improved targeting of intracellular leishmania parasites.
- To assess the pharmacokinetic profile and safety of the novel PM-MS formulation.
Main Methods:
- Development of PM-loaded albumin microspheres (PM-MS).
- Establishment and validation of a sensitive bioanalytical method for quantifying PM in rat plasma.
- Pharmacokinetic studies comparing PM and PM-MS administered via intramuscular and intravenous routes.
- Acute and subacute toxicity evaluations of PM and PM-MS formulations.
Main Results:
- A sensitive bioanalytical method with a quantification limit of 40 ng/ml was developed.
- PM-MS administration resulted in an approximately 80% reduction in C(max) compared to other formulations.
- Toxicity studies revealed no adverse effects for PM-MS at 90 mg/kg, unlike PM intramuscular injection which increased blood urea and BUN levels.
Conclusions:
- PM-MS formulation demonstrates enhanced pharmacokinetic properties and a favorable safety profile.
- The developed PM-MS represents a promising alternative to current paromomycin intramuscular injections for visceral leishmaniasis treatment.
More Related Videos
Related Concept Videos
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
Therapeutic Drug Monitoring: Drug Analysis Methods
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Estimation of k and VD of Aminoglycosides
Measurement of Bioavailability: Pharmacokinetic Methods

